Click here to download PDF Version of the final programme (1.8 MB)

Search through the abstracts in detail! Click here to start!

About the Agenda Builder

The agenda builder is a simple, light-weight tool to manage your schedule. There are filters to narrow your search by day, track and/or presenter.

  • To use, simply click the "Add to my agenda" link. The  selected item will remain in memory indefinitely. 
  • Limitation: It will only "remember" the computer employed AND as long as you do not erase your "cookies".

:   :   :

:   :   Search

HPV 2010
 
Programme

>> Day 1 - Saturday, July 3, 2010

Time Description Room Expand all sessions
08:35 AM
Clinical Workshop - Session 1: Natural history and screening concept
Chair(s):
Anthony B. Miller, Toronto, Canada
Joakim Dillner, Malmö, Sweden
 517a
 Show details
08:35 AM
    L   
Welcome & Opening Remarks
Xavier Bosch [Bio]
Director, Research Program of Cancer Epidemiology, Catalan Oncology Institute (ICO)
Barcelona, Spain
517a
 Add to my agenda
08:45 AM
    L   
The burden of high risk HPV
Xavier Bosch [Bio]
Director, Research Program of Cancer Epidemiology, Catalan Oncology Institute (ICO)
Barcelona, Spain
517a
 Add to my agenda
09:00 AM
    L   
HPV: natural history of the infection from the biological perspective
John Doorbar
Group Leader, Division of Virology, National Institute for Medical Research
London, United Kingdom
517a
 Add to my agenda
09:15 AM
    L   
HPV: natural history of the infection from the epidemiological and clinical perspective
Mark Schiffman [Bio]
Senior Investigator, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health
Rockville, USA
517a
 Add to my agenda
09:30 AM
    L   
HPV: natural history of the infection in younger women
Anna-Barbara Moscicki [Bio]
Professor of Pediatrics and Director for Clinical Services, University of California
San Francisco, USA
517a
 Add to my agenda
09:45 AM
    L   
Questions & Answers
517a
 Add to my agenda
10:00 AM
    L   
Coffee Break
517a
 Add to my agenda
10:30 AM
    L   
Cervical cancer screening; the principles and evaluation parameters of the programme
Anthony B. Miller [Bio]
Professor, Epidemiology and Social and Behavioral Health Sciences, Dalla Lana School of Public Health
Toronto, Canada
517a
 Add to my agenda
10:45 AM
    L   
Cytology-based cervical cancer screening
Ahti Anttila [Bio]
Research Director of the Mass Screening Registry, Finnish Cancer Registry, Mass Screening Registry
Helsinki, Finland
517a
 Add to my agenda
11:00 AM
    L   
Biological markers in cervical cancer screening
Chris J.L.M. Meijer
Professor, Department of Pathology, Vrije University Medical Center
Amsterdam, The Netherlands
517a
 Add to my agenda
11:15 AM
    L   
Questions & Answers
517a
 Add to my agenda
11:30 AM
Clinical Workshop - Lunch
 517a
 Add to my agenda
12:45 PM
Clinical Workshop - Session 2: The comprehensive value of HPV tests in prevention and management
Chair(s):
Marc Arbyn, Brussels, Belgium
 517a
 Show details
12:45 PM
    L   
Testing for HPV. Requirements for clinical use and usefulness of HPV typing in the clinical practice
François Coutlée [Bio]
Professor, Microbiology and Immunology, Université de Montréal
Montreal, Canada
517a
 Add to my agenda
01:00 PM
    L   
HPV testing for primary screening
Marie-Hélène Mayrand [Bio]
Chercheur, Faculté de médecine, Départements de Gynécologie et de Médecine Sociale et Préventive, Université de Montréal et CHUM
Montréal, Canada
517a
 Add to my agenda
01:15 PM
    L   
HPV testing for the triage of ASCUS and LSIL; principles and results
Phillip Castle [Bio]
Investigator, National Cancer Institute, National Institutes of Health
Bethesda, USA
517a
 Add to my agenda
01:30 PM
    L   
HPV tests in the post-treatment follow up
Marc Arbyn
Unit of Cancer Epidemiology, Scientific Institute of Public Health
Brussels, Belgium
517a
 Add to my agenda
01:45 PM
    L   
Follow up and counseling for HPV+ women with normal smears
Gina Ogilvie [Bio]
Associate Medical Director, Division of STI/HIV Prevention and Control, BC Centre for Disease Control
Vancouver, Canada
517a
 Add to my agenda
02:00 PM
    L   
Cervical screening in populations vaccinated against HPV
Thomas C. Wright, Jr.
Professor of Pathology and Cell Biology, Columbia University
, USA
517a
 Add to my agenda
02:15 PM
    L   
Questions & Answers
517a
 Add to my agenda
02:30 PM
    L   
Coffee Break
517a
 Add to my agenda
03:00 PM
    L   
Follow up, counseling and treatment issues in pre neoplastic cervical diseases
J. Thomas Cox [Bio]
Director of Women's Health, University of California
Santa Barbara, USA
517a
 Add to my agenda
03:15 PM
    L   
Multifocal HPV disease and implication for long term follow-up
Alice Lytwyn [Bio]
Associate Professor of Pathology and Molecular Medicine and Resident Research Coordinator, Anatomical Pathology, McMaster University
Hamilton, Canada
517a
 Add to my agenda
03:30 PM
    L   
Rational transition from research studies to implementation in programmes
Jack Cuzick [Bio]
John Snow Professor of Epidemiology, Head of Department, Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Queen Mary, University of London, Wolfson Institute of Preventive Medicine
London, United Kingdom
517a
 Add to my agenda
03:45 PM
    L   
Sustainable screening for developing countries
Jose A. Jeronimo [Bio]
Director START-UP Project, Reproductive Health, PATH
Seattle, USA
517a
 Add to my agenda
04:00 PM
    L   
Questions & Answers
517a
 Add to my agenda
04:15 PM
    L   
Closing Comments
Phillip Castle [Bio]
Investigator, National Cancer Institute, National Institutes of Health
Bethesda, USA
517a
 Add to my agenda

Innovator_V2